Cardinal Health Posts a Big Q1 Loss Due to Opioid Litigation but Still Beats Estimates
Distributing pharmaceuticals and medical supplies might not seem like a very exciting business. But Cardinal Health (NYSE: CAH) has delivered some excitement for investors so far in 2019, with its stock rising 15% year to date. And it appears that more gains are on the way.
The company announced its fiscal 2020 first-quarter results before the market opened on Thursday, giving investors some good news. Here are the highlights from Cardinal Health's Q1 update.
Image source: Getty Images
Source Fool.com
